Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Samorita HospitalDHA:SAMORITA +2.11%18 Equity-to-Asset is 0.00 as of . 20. GuruFocus rates DHA:SAMORITA with a GF Score™ of 18/100. The stock has 1 warning sign investors should review. Among 685 Healthcare Providers & Services companies, Samorita Hospital ranks worse than 145985.26% on this metric.
The historical rank and industry rank for Samorita Hospital's Equity-to-Asset or its related term are showing as below:
DHA:SAMORITA's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.48 * Ranked among companies with meaningful Equity-to-Asset only.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Samorita Hospital Equity-to-Asset Related Terms
Samorita Hospital Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Samorita Hospital's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samorita Hospital Equity-to-Asset Chart
Samorita Hospital Annual Data
Trend
Equity-to-Asset
Samorita Hospital Semi-Annual Data
Equity-to-Asset
DHA:SAMORITA vs SPIN, USNU, CHCR: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, Samorita Hospital's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samorita Hospital Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Samorita Hospital's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Samorita Hospital's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Samorita Hospital's Equity to Asset Ratio for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samorita Hospital (DHA:SAMORITA) has a Equity-to-Asset of 0.00 as of . 20. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Samorita Hospital and its competitors. According to the industry distribution chart, Samorita Hospital ranks #999999 out of 685 companies in the Healthcare Providers & Services industry.
Is Samorita Hospital's Equity-to-Asset too high?
Samorita Hospital's current Equity-to-Asset is 0.00. Based on the distribution chart, Samorita Hospital ranks #999999 out of 685 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Samorita Hospital has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Samorita Hospital's Equity-to-Asset compare to SPIN and USNU?
According to the Healthcare Providers & Services industry distribution chart, Samorita Hospital ranks #999999 out of 685 companies for Equity-to-Asset. This places Samorita Hospital in the lower half of its industry. The industry median Equity-to-Asset is 0.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Samorita Hospital and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Samorita Hospital's current Equity-to-Asset is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samorita Hospital stock overvalued right now?
Samorita Hospital (DHA:SAMORITA) has a current Equity-to-Asset of 0.00. The current Equity-to-Asset is 0.00. Samorita Hospital's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Samorita Hospital (DHA:SAMORITA), the current Equity-to-Asset is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Samorita Hospital Ltd provides general hospital services including all types of medical treatment along with diagnostic services in Bangladesh. It offers various clinical services in the areas of internal medicine, neurology, diabetes and endocrinology, nephrology, respiratory medicine, gastroenterology and other.
18GF Score
Get the complete analysis for DHA:SAMORITA
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:SAMORITA has been successfully added to your 
